These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16493449)

  • 21. Contribution of IBD5 locus to clinical features of IBD patients.
    Latiano A; Palmieri O; Valvano RM; D'Incà R; Vecchi M; Ferraris A; Sturniolo GC; Spina L; Lombardi G; Dallapiccola B; Andriulli A; Devoto M; Annese V
    Am J Gastroenterol; 2006 Feb; 101(2):318-25. PubMed ID: 16454837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.
    Waschke KA; Villani AC; Vermeire S; Dufresne L; Chen TC; Bitton A; Cohen A; Thomson AB; Wild GE
    Am J Gastroenterol; 2005 May; 100(5):1126-33. PubMed ID: 15842589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical applications of NOD2/CARD15 mutations in Crohn's disease.
    Barreiro-de Acosta M; Peña AS
    Acta Gastroenterol Latinoam; 2007 Mar; 37(1):49-54. PubMed ID: 17486745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.
    Török HP; Glas J; Tonenchi L; Lohse P; Müller-Myhsok B; Limbersky O; Neugebauer C; Schnitzler F; Seiderer J; Tillack C; Brand S; Brünnler G; Jagiello P; Epplen JT; Griga T; Klein W; Schiemann U; Folwaczny M; Ochsenkühn T; Folwaczny C
    Gut; 2005 Oct; 54(10):1421-7. PubMed ID: 15955786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
    Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
    PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population.
    Pearce AV; Fisher SA; Prescott NJ; Onnie CM; Pattni R; Green P; Forbes A; Mansfield J; Sanderson J; Schreiber S; Lewis CM; Mathew CG
    Int J Colorectal Dis; 2007 Apr; 22(4):419-24. PubMed ID: 16944184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
    Büning C; Schmidt HH; Molnar T; De Jong DJ; Fiedler T; Bühner S; Sturm A; Baumgart DC; Nagy F; Lonovics J; Drenth JP; Landt O; Nickel R; Büttner J; Lochs H; Witt H
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1025-33. PubMed ID: 17877509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease.
    Tosa M; Negoro K; Kinouchi Y; Abe H; Nomura E; Takagi S; Aihara H; Oomori S; Sugimura M; Takahashi K; Hiwatashi N; Takahashi S; Shimosegawa T
    Scand J Gastroenterol; 2006 Jan; 41(1):48-53. PubMed ID: 16373276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.
    Noble CL; Nimmo ER; Drummond H; Smith L; Arnott ID; Satsangi J
    Gut; 2005 Oct; 54(10):1416-20. PubMed ID: 15843420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
    Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
    Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease.
    Chua KH; Hilmi I; Ng CC; Eng TL; Palaniappan S; Lee WS; Goh KL
    J Dig Dis; 2009 May; 10(2):124-30. PubMed ID: 19426395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases.
    Cucchiara S; Latiano A; Palmieri O; Staiano AM; D'Incà R; Guariso G; Vieni G; Rutigliano V; Borrelli O; Valvano MR; Annese V
    World J Gastroenterol; 2007 Feb; 13(8):1221-9. PubMed ID: 17451203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children.
    Amre DK; Mack D; Israel D; Morgan K; Lambrette P; Law L; Grimard G; Deslandres C; Krupoves A; Bucionis V; Costea I; Bissonauth V; Feguery H; D'Souza S; Levy E; Seidman EG
    Am J Gastroenterol; 2008 Mar; 103(3):615-20. PubMed ID: 18047539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
    Figueroa C; Peralta A; Herrera L; Castro P; Gutiérrez A; Valenzuela J; Aguillón JC; Quera R; Hermoso MA
    Eur Cytokine Netw; 2006 Jun; 17(2):125-30. PubMed ID: 16840031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diverse effects of the CARD15 and IBD5 loci on clinical phenotype in 630 patients with Crohn's disease.
    Onnie CM; Fisher SA; Prescott NJ; Mirza MM; Green P; Sanderson J; Forbes A; Lewis CM; Mathew CG
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):37-45. PubMed ID: 18090989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease.
    Jess T; Riis L; Jespersgaard C; Hougs L; Andersen PS; Orholm MK; Binder V; Munkholm P
    Am J Gastroenterol; 2005 Nov; 100(11):2486-92. PubMed ID: 16279904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of genotype-phenotype relationships and stratification by the CARD15 variant genotype for inflammatory bowel disease susceptibility loci using multiple short tandem repeat genetic markers.
    Crawford NP; Colliver DW; Funke AA; Young MN; Kelley S; Cobbs GA; Petras RE; Galandiuk S
    Hum Mutat; 2005 Feb; 25(2):156-66. PubMed ID: 15643611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
    Petermann I; Huebner C; Browning BL; Gearry RB; Barclay ML; Kennedy M; Roberts R; Shelling AN; Philpott M; Han DY; Ferguson LR
    Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?
    Buhner S; Buning C; Genschel J; Kling K; Herrmann D; Dignass A; Kuechler I; Krueger S; Schmidt HH; Lochs H
    Gut; 2006 Mar; 55(3):342-7. PubMed ID: 16000642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the molecular dissection of inflammatory bowel disease.
    Siminovitch KA
    Semin Immunol; 2006 Aug; 18(4):244-53. PubMed ID: 16679026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.